Form 8-K - Current report:
SEC Accession No. 0001193125-24-246602
Filing Date
2024-10-29
Accepted
2024-10-29 16:43:54
Documents
17
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d899591d8k.htm   iXBRL 8-K 40207
2 EX-4.1 d899591dex41.htm EX-4.1 94915
3 EX-5.1 d899591dex51.htm EX-5.1 7134
4 EX-10.1 d899591dex101.htm EX-10.1 204407
8 GRAPHIC g899591g1029114410582.jpg GRAPHIC 2337
  Complete submission text file 0001193125-24-246602.txt   571956

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bior-20241028.xsd EX-101.SCH 2870
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bior-20241028_lab.xml EX-101.LAB 18739
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bior-20241028_pre.xml EX-101.PRE 11721
19 EXTRACTED XBRL INSTANCE DOCUMENT d899591d8k_htm.xml XML 3778
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241406351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)